Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Enterprise value

Enterprise value at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$16.37B+47.7%
Alkermes logo
AlkermesALKS
$7.12B+41.2%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$8.56B+52.9%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.77B+1,855%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$6.34B+33.4%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.56B+36.6%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

$1.6Bmarket cap+$164.6Mtotal debt−$589.4Mcash and equivalents=$1.2B

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s enterprise value?
Harmony Biosciences Holdings, Inc. (HRMY) reported enterprise value of $1.2B in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s enterprise value changed year-over-year?
Harmony Biosciences Holdings, Inc.'s enterprise value decreased by 24.9% year-over-year, from $1.59B to $1.2B.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s enterprise value has grown at a -4.9% compound annual growth rate (CAGR), from $2.02B to $1.57B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.